Quantum BioPharma 加入这一趋势，将 100 万美元的资金投入比特币

埃里温 (CoinChapter.com)——Quantum BioPharma 透露其于 12 月 20 日购买了 100 万美元的比特币和其他加密货币。

Quantum BioPharma (NASDAQ: QBIO) announced on Tuesday that it purchased $1 million worth of Bitcoin and other cryptocurrencies. This decision is part of the company’s strategy to diversify its treasury and engage in cryptocurrency transactions. However, the announcement led to a 10% drop in its Nasdaq shares.

Quantum BioPharma（纳斯达克股票代码：QBIO）周二宣布购买了价值 100 万美元的比特币和其他加密货币。这一决定是该公司财务多元化和从事加密货币交易战略的一部分。然而，这一消息导致其纳斯达克股价下跌10%。

The company did not disclose which specific tokens were included in its cryptocurrency portfolio. In a statement, Quantum BioPharma said it is now equipped to receive financing and conduct transactions using cryptocurrency.

该公司没有透露其加密货币投资组合中包含哪些具体代币。 Quantum BioPharma 在一份声明中表示，它现在有能力接受融资并使用加密货币进行交易。

Increasing Corporate Adoption of Bitcoin

越来越多的企业采用比特币

Quantum BioPharma’s move reflects a growing trend of companies adopting Bitcoin and other cryptocurrencies as part of their treasury management strategies. In November, Jiva Technologies, a wellness-focused e-commerce company, invested $1 million in Bitcoin, citing its potential as an inflation hedge. Similarly, video-sharing platform Rumble allocated $20 million from its cash reserves to Bitcoin last month.

Quantum BioPharma 的举动反映了越来越多的公司采用比特币和其他加密货币作为其财务管理策略的一部分。去年 11 月，专注于健康的电子商务公司 Jiva Technologies 投资了 100 万美元比特币，理由是比特币具有对冲通胀的潜力。同样，视频共享平台 Rumble 上个月从其现金储备中拨出 2000 万美元购买比特币。

Another biopharmaceutical company, Hoth Therapeutics, also joined the trend by investing $1 million in Bitcoin in November. These investments highlight the increasing interest of non-crypto businesses in digital assets.

另一家生物制药公司 Hoth Therapeutics 也加入了这一趋势，于 11 月投资了 100 万美元的比特币。这些投资凸显了非加密企业对数字资产日益增长的兴趣。

Cryptocurrency as a Hedge Against Inflation

加密货币作为通胀对冲工具

The latest US Consumer Price Index (CPI) data indicates that inflation rose by 2.7% year-over-year in November 2024, compared to 2.6% in October. This marks the sharpest monthly increase in seven months.

最新的美国消费者价格指数（CPI）数据显示，2024 年 11 月通胀同比上涨 2.7%，而 10 月份为 2.6%。这标志着七个月来的最大月度增幅。

Companies are looking to Bitcoin as a potential hedge against such inflationary pressures, driving further interest in cryptocurrency treasury strategies.

公司正在将比特币视为对抗此类通胀压力的潜在对冲工具，这进一步推动了人们对加密货币财务策略的兴趣。

Quantum BioPharma’s Role in Biotech and Crypto Adoption

量子生物制药在生物技术和加密货币采用中的作用

Quantum BioPharma operates in the biopharmaceutical sector, offering biotech solutions for treating neurodegenerative diseases, metabolic syndromes, and alcohol misuse disorders. Listed on the Nasdaq, Canadian Securities Exchange, and Frankfurt Stock Exchange, the company is part of a broader movement integrating cryptocurrencies into traditional industries.

Quantum BioPharma 从事生物制药领域的业务，提供治疗神经退行性疾病、代谢综合征和酒精滥用障碍的生物技术解决方案。该公司在纳斯达克、加拿大证券交易所和法兰克福证券交易所上市，是加密货币融入传统行业的更广泛运动的一部分。

By adopting cryptocurrency for treasury management and transactions, Quantum BioPharma reflects the increasing synergy between traditional industries and digital assets.

通过采用加密货币进行资金管理和交易，量子生物制药体现了传统行业与数字资产之间日益增强的协同作用。

Push for Bitcoin in Corporate Treasuries

推动比特币进入企业金库

Organizations are also encouraging major corporations to explore Bitcoin. The National Center for Public Policy Research, a think tank based in Washington, recently proposed that Microsoft and Amazon consider Bitcoin treasury strategies.

各组织还鼓励大公司探索比特币。总部位于华盛顿的智库国家公共政策研究中心最近提议微软和亚马逊考虑比特币金库策略。

At Microsoft’s annual meeting on Dec. 10, shareholders voted against this proposal, with the company labeling it “unnecessary.” Amazon shareholders are set to discuss a similar resolution in April 2025. The think tank plans to continue advocating for Bitcoin adoption in corporate treasuries in 2025.

在 12 月 10 日的微软年会上，股东们投票反对了这一提议，公司称其“没有必要”。亚马逊股东将于 2025 年 4 月讨论类似的决议。该智库计划在 2025 年继续倡导在企业财务中采用比特币。

MicroStrategy Leads Bitcoin Holdings

MicroStrategy 引领比特币持有量

Among corporations, MicroStrategy remains the largest Bitcoin holder, with 439,000 BTC as of December 2024. The company’s long-standing strategy of acquiring Bitcoin has influenced other firms, including Quantum BioPharma, to explore cryptocurrency as part of their treasury assets.

在企业中，MicroStrategy 仍然是最大的比特币持有者，截至 2024 年 12 月拥有 439,000 BTC。该公司收购比特币的长期战略影响了包括 Quantum BioPharma 在内的其他公司，探索将加密货币作为其财务资产的一部分。

Quantum BioPharma’s $1 million investment in Bitcoin places it among a growing list of companies integrating digital assets into their financial strategies.

Quantum BioPharma 对比特币的 100 万美元投资使其成为越来越多将数字资产纳入其财务战略的公司之一。